Before you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.
There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.
A small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.
Many patients with osteoarthritis turn to complementary and alternative medicine, either as an adjunct to prescription therapy or to avoid side effects.
With more and more students applying for residency positions, off-site interviews are becoming an important first step in the selection process.
As a whole, adult vaccination coverage has remained unchanged without significant improvement.
Among patients with poor statin adherence, adequate antidepressant treatment significantly improved adherence and persistence compared with inadequate or no antidepressant treatment.
Neighborhood pharmacists can provide support and information.
The new process takes into account the efficacy, risk, cost, and societal benefit of a given specialty drug in determining whether it should be added to the hospital's formulary.
Diabetes is a complex disease affecting 29.1 million individuals in the United States.
A new healthcare role will help bridge the gap between hospital, primary care, and home for patients.
In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.
In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
The SUNY Outpatient Pharmacy has developed a strong collaboration with specialty pharmacy personnel and clinically embedded pharmacists.
Suboptimal adherence to hormone therapy was associated with higher medical costs, but optimal adherence was not associated with total cost savings across a 4-year period.
Breakthrough pain estimates vary, but as many as 50% of patients diagnosed with cancer and chronic pain have pain levels that are not adequately controlled
This Continuing Education activity is supported by an educational grant from Teva Pharmaceuticals and Merck Sharp & Dohme Corp.
More than 100 patients at a hospital in Los Angeles may have been exposed to a "superbug" that has been linked to at least 2 deaths at the facility.
On February 14, 2018, the FDA approved apalutamide (Erleada) by Janssen Biotech Inc for the treatment of nonmetastatic castration-resistant prostate cancer (NM-CRPC).
A majority of life sciences companies are planning on acquisitions and are targeting companies with a personalized medicine focus.
Developing industry connections is crucial for aspiring pharmacists.